Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin F Bachmann

Showing results (141-150 of 250) with videos related to

Pageof 25
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|September 25, 2008
Isolation of human monoclonal antibodies by mammalian cell displayRoger R Beerli, Monika Bauer, Regula B Buser, et al.
Intervirology|February 5, 2003
Virus-like particles as a modular system for novel vaccinesFranziska Lechner, Andrea Jegerlehner, Alain C Tissot, et al.
International Archives of Allergy and Immunology|March 11, 2020
A Single Monoclonal Antibody against the Peanut Allergen Ara h 2 Protects against Systemic and Local Peanut AllergyFederico Storni, Gustavo Cabral-Miranda, Elisa Roesti, et al.
Biotechniques|December 16, 2004
Rapid functional cloning of cell adhesion moleculesChristiane Ruedl, Monika Bauer, Roger R Beerli, et al.
The Journal of Experimental Medicine|April 25, 2024
Regulation of pulmonary plasma cell responses during secondary infection with influenza virusAndrew J MacLean, Joao P P L Bonifacio, Sophia L Oram, et al.
European Journal of Immunology|October 14, 2006
Neutralization of IL-17 by active vaccination inhibits IL-23-dependent autoimmune myocarditisIvo Sonderegger, Till A Röhn, Michael O Kurrer, et al.
Virology Journal|July 8, 2010
A VLP-based vaccine targeting domain III of the West Nile virus E protein protects from lethal infection in miceGunther Spohn, Gary T Jennings, Byron Ee Martina, et al.
Frontiers in Immunology|March 22, 2017
Adjusted Particle Size Eliminates the Need of Linkage of Antigen and Adjuvants for Appropriated T Cell Responses in Virus-Like Particle-Based VaccinesAriane C Gomes, Anna Flace, Philippe Saudan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 9, 2002
Critical role for activation of antigen-presenting cells in priming of cytotoxic T cell responses after vaccination with virus-like particlesTazio Storni, Franziska Lechner, Iris Erdmann, et al.
Immunity|April 5, 2008
Constitutive crosspresentation of tissue antigens by dendritic cells controls CD8+ T cell tolerance in vivoNancy Luckashenak, Samira Schroeder, Katrin Endt, et al.
Pageof 25

Showing results (141-150 of 250) with videos related to

Sort By:
Pageof 25
Proceedings of the National Academy of Sciences of the United States of America|September 25, 2008
Isolation of human monoclonal antibodies by mammalian cell displayRoger R Beerli, Monika Bauer, Regula B Buser, et al.
Intervirology|February 5, 2003
Virus-like particles as a modular system for novel vaccinesFranziska Lechner, Andrea Jegerlehner, Alain C Tissot, et al.
International Archives of Allergy and Immunology|March 11, 2020
A Single Monoclonal Antibody against the Peanut Allergen Ara h 2 Protects against Systemic and Local Peanut AllergyFederico Storni, Gustavo Cabral-Miranda, Elisa Roesti, et al.
Biotechniques|December 16, 2004
Rapid functional cloning of cell adhesion moleculesChristiane Ruedl, Monika Bauer, Roger R Beerli, et al.
The Journal of Experimental Medicine|April 25, 2024
Regulation of pulmonary plasma cell responses during secondary infection with influenza virusAndrew J MacLean, Joao P P L Bonifacio, Sophia L Oram, et al.
European Journal of Immunology|October 14, 2006
Neutralization of IL-17 by active vaccination inhibits IL-23-dependent autoimmune myocarditisIvo Sonderegger, Till A Röhn, Michael O Kurrer, et al.
Virology Journal|July 8, 2010
A VLP-based vaccine targeting domain III of the West Nile virus E protein protects from lethal infection in miceGunther Spohn, Gary T Jennings, Byron Ee Martina, et al.
Frontiers in Immunology|March 22, 2017
Adjusted Particle Size Eliminates the Need of Linkage of Antigen and Adjuvants for Appropriated T Cell Responses in Virus-Like Particle-Based VaccinesAriane C Gomes, Anna Flace, Philippe Saudan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 9, 2002
Critical role for activation of antigen-presenting cells in priming of cytotoxic T cell responses after vaccination with virus-like particlesTazio Storni, Franziska Lechner, Iris Erdmann, et al.
Immunity|April 5, 2008
Constitutive crosspresentation of tissue antigens by dendritic cells controls CD8+ T cell tolerance in vivoNancy Luckashenak, Samira Schroeder, Katrin Endt, et al.
Pageof 25